138 related articles for article (PubMed ID: 22554615)
1. Drug-mediated toxicity: illuminating the 'bad' in the test tube by means of cellular assays?
Tralau T; Luch A
Trends Pharmacol Sci; 2012 Jul; 33(7):353-64. PubMed ID: 22554615
[TBL] [Abstract][Full Text] [Related]
2. Improved preclinical safety assessment using micro-BAL devices: the potential impact on human discovery and drug attrition.
Giri S; Bader A
Drug Discov Today; 2011 May; 16(9-10):382-97. PubMed ID: 21354326
[TBL] [Abstract][Full Text] [Related]
3. Review of the performance of the 3T3 NRU in vitro phototoxicity assay in the pharmaceutical industry.
Lynch AM; Wilcox P
Exp Toxicol Pathol; 2011 Mar; 63(3):209-14. PubMed ID: 20060695
[TBL] [Abstract][Full Text] [Related]
4. Preclinical assessment of cardiac toxicity.
Kettenhofen R; Bohlen H
Drug Discov Today; 2008 Aug; 13(15-16):702-7. PubMed ID: 18602016
[TBL] [Abstract][Full Text] [Related]
5. Metabolites in safety testing.
Robison TW; Jacobs A
Bioanalysis; 2009 Oct; 1(7):1193-200. PubMed ID: 21083045
[TBL] [Abstract][Full Text] [Related]
6. Concise review: Human pluripotent stem cell-based models for cardiac and hepatic toxicity assessment.
Sartipy P; Björquist P
Stem Cells; 2011 May; 29(5):744-8. PubMed ID: 21433222
[TBL] [Abstract][Full Text] [Related]
7. Embryonic stem cell test: stem cell use in predicting developmental cardiotoxicity and osteotoxicity.
Kuske B; Pulyanina PY; zur Nieden NI
Methods Mol Biol; 2012; 889():147-79. PubMed ID: 22669664
[TBL] [Abstract][Full Text] [Related]
8. Optimising the design of preliminary toxicity studies for pharmaceutical safety testing in the dog.
Smith D; Combes R; Depelchin O; Jacobsen SD; Hack R; Luft J; Lammens L; von Landenberg F; Phillips B; Pfister R; Rabemampianina Y; Sparrow S; Stark C; Stephan-Gueldner M
Regul Toxicol Pharmacol; 2005 Mar; 41(2):95-101. PubMed ID: 15698532
[TBL] [Abstract][Full Text] [Related]
9. Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development.
Whitebread S; Hamon J; Bojanic D; Urban L
Drug Discov Today; 2005 Nov; 10(21):1421-33. PubMed ID: 16243262
[TBL] [Abstract][Full Text] [Related]
10. Serum chemical biomarkers of cardiac injury for nonclinical safety testing.
Walker DB
Toxicol Pathol; 2006; 34(1):94-104. PubMed ID: 16507550
[TBL] [Abstract][Full Text] [Related]
11. Interpretation of uniform-well readouts.
Josiah S
Methods Mol Biol; 2009; 486():177-92. PubMed ID: 19347624
[TBL] [Abstract][Full Text] [Related]
12. A search to predict potential for drug-induced cardiovascular toxicity.
Hamlin RL
Toxicol Pathol; 2006; 34(1):75-80. PubMed ID: 16507547
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Vitotox and RadarScreen assays for the rapid assessment of genotoxicity in the early research phase of drug development.
Westerink WM; Stevenson JC; Lauwers A; Griffioen G; Horbach GJ; Schoonen WG
Mutat Res; 2009 May; 676(1-2):113-30. PubMed ID: 19393335
[TBL] [Abstract][Full Text] [Related]
14. Preclinical Torsades-de-Pointes screens: advantages and limitations of surrogate and direct approaches in evaluating proarrhythmic risk.
Gintant GA
Pharmacol Ther; 2008 Aug; 119(2):199-209. PubMed ID: 18621077
[TBL] [Abstract][Full Text] [Related]
15. What have we learned from pre-clinical juvenile toxicity studies?
Bailey GP; Mariën D
Reprod Toxicol; 2009 Sep; 28(2):226-9. PubMed ID: 19446432
[TBL] [Abstract][Full Text] [Related]
16. Retinal and ocular toxicity in ocular application of drugs and chemicals--part I: animal models and toxicity assays.
Penha FM; Rodrigues EB; Maia M; Dib E; Fiod Costa E; Furlani BA; Nunes Moraes Filho M; Dreyfuss JL; Bottós J; Farah ME
Ophthalmic Res; 2010; 44(2):82-104. PubMed ID: 20484950
[TBL] [Abstract][Full Text] [Related]
17. High-throughput human metabolism and toxicity analysis.
Lee MY; Dordick JS
Curr Opin Biotechnol; 2006 Dec; 17(6):619-27. PubMed ID: 17046235
[TBL] [Abstract][Full Text] [Related]
18. Integrating metabolism and toxicity in multi-organ systems.
Madden S; Bach PH
Curr Opin Drug Discov Devel; 2001 Jan; 4(1):66-72. PubMed ID: 11727325
[TBL] [Abstract][Full Text] [Related]
19. GABAA receptor and cell membrane potential as functional endpoints in cultured neurons to evaluate chemicals for human acute toxicity.
Galofré M; Babot Z; García DA; Iraola S; Rodríguez-Farré E; Forsby A; Suñol C
Neurotoxicol Teratol; 2010; 32(1):52-61. PubMed ID: 19602384
[TBL] [Abstract][Full Text] [Related]
20. High content cellular screening.
Rausch O
Curr Opin Chem Biol; 2006 Aug; 10(4):316-20. PubMed ID: 16793326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]